US EditionChina pharma firms turn to local reagent suppliers to cut costs and delivery times
9 Articles
9 Articles
China pharma firms turn to local reagent suppliers to cut costs and delivery times
Pharmaceutical research and development firms in China are increasingly interested in procuring critical supplies known as reagents from local manufacturers, industry executives and managers said, as they seek to cut costs and delivery times.
PEKIN.— Pharmaceutical research and development companies in China show growing interest in acquiring critical supplies, known as reagents, from local manufacturers, according to industry executives and managers, in an effort to reduce costs and shorten delivery times. Western reagent suppliers, such as the American Thermo Fisher Scientific and the German Merck (MRCG.DE), have made profits in the second largest pharmaceutical market in the world…
China Shifts to Domestic Reagents Amid Tariff Pressures
Pharmaceutical research and development companies in China are increasingly turning to locally manufactured reagents, driven by a need to cut costs, reduce delivery times, and navigate trade uncertainties, according to industry executives. For years, Western suppliers like U.S.-based Thermo Fisher Scientific and Germany’s Merck dominated China’s reagent market — key compounds used in laboratory testing, analysis, and quality control. However, ri…
Coverage Details
Bias Distribution
- 83% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
